Kureha Corp. engages in the manufacture and sale of chemical products for pharmaceuticals, agrochemicals, and packaging materials. It operates through the following segments: Functional Products, Chemical Products, Resin Products, Construction-related Business, and Others. The Functional Products segment produces Polyphenylene Sulfide (PPS) resin, Polyvinylidene Fluoride, and carbon products. The Chemical Products segment develops and markets industrial chemicals, pharmaceutical products, and pesticides. The Resin Products segment includes food packaging materials and household goods. The Construction-related Business segment deals with construction and engineering services. The Others segment covers environmental-related businesses and logistics. The company was founded on June 21, 1944 and is headquartered in Tokyo, Japan.

Ossacur GmbH is a private company headquartered in Oberstenfeld, Germany. The firm provides investment services.

CoorsTek, Inc. is a privately owned manufacturer of technical ceramics for aerospace, automotive, chemical, electronics, medical, metallurgical, oil and gas, semiconductor and many other industries. CoorsTek headquarters and primary factories are located in Golden, Colorado, USA, near the foothills west of Denver. The company is wholly owned by Keystone Holdings LLC, a trust of the Coors family. The president and chairman is John K. Coors, a great-grandson of founder and brewing magnate Adolph Coors, Sr., and the fifth and youngest son of longtime chairman and president Joseph Coors.

Markets pharmaceutical specialties & personal products

Sichuan Jinzhengfang Cable Co., Ltd., established on 2013-12-06, Business scope includes licensed projects:electric wire,cable manufacturing.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,The specific business items are subject to the approval documents or licenses of relevant departments)General project:Electrical equipment manufacturing;Electrical Equipment Sales;Research and development of high-efficiency and energy-saving technologies in the power industry;Manufacture of power distribution switch control equipment;Distribution switch control equipment sales;Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion;New material technology research and development;Import and export;Non-residential real estate leases.(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license)

BEGO Bremer Goldschlägerei Wilh. Herbst GmbH & Co. KG, part of BEGO GmbH & Co. KG, is a company headquartered in Bremen, Germany, that manufactures and develops dental equipment and supplies. Axel Klarmeyer and Christoph Weiss are the current co-CEOs of the firm.

Bioventus is a global leader of active orthopaedic healing, providing clinically proven and cost-effective therapies and diagnostics that help patients regain active lifestyles. Bioventus' products are known for their innovation, safety and effectiveness. The company is the recognized leader in bone stimulation devices and among the leading distributors of osteoarthritis joint fluid therapies. Key products include: - EXOGEN(r) Ultrasound Bone Healing System - SUPARTZ(r) Joint Fluid Therapy (US only) - DUROLANE(r) Hyaluronic Acid, Single Injection (Outside US only) Bioventus' adherence to high quality standards, commitment to evidence-based medicine and strong ethical behavior makes the company a trusted partner for thousands of physicians worldwide. Bioventus employs 500 people and generates about $240 million in yearly revenue. The company is headquartered in Durham, N.C. Prior to launch in 2012, Bioventus was operating as the Biologics Division of Smith & Nephew.

CG Bio Co., Ltd. is a private company headquartered in Seongnam, the South Korea, with subsidiaries in that country, specializing in surgical and medical instruments and apparatus. It was founded in 2006. Hyun-Seung Yoo is currently the CEO of the firm.

Foshan Mingqian Technology Co., Ltd., established on 2014-11-19, Business scope includes services:electronic product,new energy,car,software,light spinning,biology,Environmental friendly,Technical development of machinery and equipment,consult,Serve,transfer;Domestic Trade.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Guangdong Bada Pharmaceutical Co., Ltd., established on 1992-05-06, Business scope includes pharmaceutical production(Production of freeze-dried powder injections);technical consulting,transfer,Serve.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Hubei Sailuo Biomaterials Co., Ltd., established on 2014-07-30, The business scope includes biomedical materials and the first,two,Research and development of three types of medical devices,Production,Sales,technical consulting;Medical Software Technical Services.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Allgens Medical Technology Co., Ltd. engages in the research, development, production, and sale of biomedical materials and related medical device products. Its researches, develops, and provides orthopedic, neurosurgical, oral, and plastic surgical mineralized collagen artificial bone repair products. The company was founded by Fu Zhai Cui on December 22, 2004 and is headquartered in Beijing, China.

Sanofi Genzyme is the specialty care global business unit of Sanofi, focused on rare diseases, multiple sclerosis, immunology, and oncology. They help people with debilitating and complex conditions that are often difficult to diagnose and treat. They are dedicated to discovering and advancing new therapies, providing hope to patients and their families around the world. Genzyme became part of Sanofi in 2011. While continuing to focus on rare diseases, they also established ourselves as a leader in the field of multiple sclerosis. In 2016, their focus expanded to include Sanofi’s programs in oncology and immunology. Their approach is shaped by a long history of developing highly specialized treatments and forging close relationships with physician and patient communities. Founded as Genzyme in Boston in 1981, they rapidly grew to become one of the world’s leading biotechnology companies, recognized for their pioneering development of treatments for rare genetic disorders and their innovative contributions to medical science and biomanufacturing.

Hangzhou Thales Medical Technology Co., Ltd., established on 2021-04-28, Business scope includes licensed projects:Production of Class II Medical Devices;Class III medical device business;Production of Class III Medical Devices(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,Specific business projects are subject to approval results).General project:Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion;software development;software sales;Information Technology Consulting Services;Technology Import and Export;Import and export;Production of Class I Medical Devices;Sales of Class II Medical Devices;Sales of Class I Medical Devices;Information system integration service;Professional Design Services;Graphic design and production;Retailing of computer software, hardware and auxiliary equipment;Data processing and storage support services;internet sales(Except for products that require a license for sale);Business Management Consulting;Medical Research and Experimental Development;Engineering and Technology Research and Experimental Development(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license).

Sinosteel Luoyang Institute of Refractories Research Co. Ltd., a subsidiary of Sinosteel Luonai Materials Technology Co., Ltd., is a Chinese company. The firm manufactures and distributes refractory materials.

The National Institute of Advanced Industrial Science and Technology (AIST), led by President Chubachi, is a public research institution funded by the Japanese government to a large extent. The present AIST is a rather new research organization established in 2001. However, AIST and its predecessor organizations have been contributing to society through continuous advancement in technologies and support to Japanese industries since 1882. Headquarters of AIST are located in Tsukuba and Tokyo. AIST has over 40 autonomous research units in various innovative research fields, and the units are located at ten research bases and several sites (smaller than research bases) of AIST all over Japan. About 2300 researchers (about 2000 with tenure: about 80 from abroad) and a few thousands of visiting scientists, post-doctoral fellows, and students from home and abroad are working at AIST. About 650 permanent administrative personnel and many temporary staff support research works of AIST.

Zhejiang Lanyi Pharmaceutical Co., Ltd., established on 2013-06-14, Business scope includes general items:Production of Class I Medical Devices;Sales of Class I Medical Devices;Sales of Class II Medical Devices;Medical equipment rental;software development;Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion;Cosmetics Wholesale;Wholesale of sporting goods and equipment;Chemical product sales(No licensed chemical products);Business agency service;property management;housing lease;Specialty Chemicals Sales(Free of Hazardous Chemicals);Manufacturing of Specialty Chemical Products(Free of Hazardous Chemicals);Land use right lease(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license).licensed items:Production of Class II Medical Devices;Production of Class III Medical Devices;Class III medical device business;Import and export;Drug import and export;Import and export agency(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,Specific business projects are subject to approval results).